Edward Hæggström

Altum Technologies Oy provides ultrasound solution that helps customers to get rid of fouling problems in their production equipment. The company was founded by Bo Malmberg, Petro Moilanen, Edward Hæggstrm, Timo Rauhala and Mikko Tainela and is headquartered in Helsinki, Finland.

Altum Technologies Oy provides ultrasound solution that helps customers to get rid of fouling problems in their production equipment. The company was founded by Bo Malmberg, Petro Moilanen, Edward Hæggstrm, Timo Rauhala and Mikko Tainela and is headquartered in Helsinki, Finland.

Altum Technologies Oy provides ultrasound solution that helps customers to get rid of fouling problems in their production equipment. The company was founded by Bo Malmberg, Petro Moilanen, Edward Hæggstrm, Timo Rauhala and Mikko Tainela and is headquartered in Helsinki, Finland.

GlucoModicum Oy is a company based in Helsinki, FI that is transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. The Finnish company's proprietary platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible, and needle-free, empowering people to live healthier lives. The company's first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. The company was founded in 2018 by Johan Bobacka. The CEO is Jokke Mäki.

Altum Technologies Oy provides ultrasound solution that helps customers to get rid of fouling problems in their production equipment. The company was founded by Bo Malmberg, Petro Moilanen, Edward Hæggstrm, Timo Rauhala and Mikko Tainela and is headquartered in Helsinki, Finland.

GlucoModicum Oy is a company based in Helsinki, FI that is transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. The Finnish company's proprietary platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible, and needle-free, empowering people to live healthier lives. The company's first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. The company was founded in 2018 by Johan Bobacka. The CEO is Jokke Mäki.